Medifast (NYSE: MED) reported Q4 EPS of ($1.65), $1.20 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $75.1 million versus the consensus estimate of $73.8 million.

For earnings history and earnings-related data on Medifast (MED) click here.